期刊
CANCER RESEARCH AND TREATMENT
卷 53, 期 2, 页码 576-583出版社
KOREAN CANCER ASSOCIATION
DOI: 10.4143/crt.2020.801
关键词
EMMPRIN (OX47); Breast neoplasms; Bone destruction; Pain
类别
资金
- National Natural Science Foundation of China [81101744]
- Projects of International Cooperation and Exchanges Natural Science Foundation of ShaanXi Province of China [2017KW-059]
- Scientific Research and Sharing Platform Construction Project of Shaanxi Province [2018PT-09]
The study demonstrates that down-regulation of EMMPRIN in tumor cells can reduce tumor burden, relieve cancer-induced bone destruction and pain. The findings suggest that EMMPRIN could be a potential therapeutic target for breast cancer bone metastasis and related complications.
Purpose Bone destruction and pain caused by cancer is one of the most devastating complications of cancer patients with bone metastases, and it seriously affects the quality of patients' life. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a cell adhesion molecule with increased expression in a variety of tumors. This study focused to clarify the specific function of EMMPRIN in bone metastasis of breast cancer. Materials and Methods Adenovirus with shRNA-EMMPRIN was transfected into MRMT-1 rat breast carcinoma cells, and the MRMT-1 cells with different expression levels of EMMPRIN were implanted into the bone marrow cavity of rat tibia. Next, the effect of down-regulation of EMMPRIN was evaluated as follows: bone damage was detected by X-ray radiological and tartrate-resistant acid phosphatase staining; the tumor burden was evaluated by hematoxylin and eosin staining; the test of pain-related behaviors was assessed used the bilateral paw withdrawal mechanical threshold; and the levels of secretory factors in tumor conditioned medium were determined by using enzyme-linked immunosorbent assay. Results We found that down-regulation of EMMPRIN in tumor cells can simultaneously reduce tumor burden, relieve cancer-induced bone destruction and pain. Conclusion EMMPRIN is expected to be a therapeutic target for relieving bone metastasis of breast cancer and alleviating cancer-induced bone destruction and pain. The method of targeting EMMPRIN may be a promising strategy for the treatment of cancer in the future.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据